InterventionsHuman trial
Glycemic Control, Weight Reduction, and Safety with CT-388, a Signal-Biased Dual GLP-1/GIP Receptor Agonist—Results from a 12-Week Cohort in Adults with Obesity and Type 2 Diabetes
ADA Scientific Sessions 2025 Abstract
The paper
STEINBERG A, ARGÜELLES-TELLO FA, SÁNCHEZ-SÁNCHEZ LL et al.
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Poster 763-P